1. Introduction
Medicinal plants have long been used as a source for traditional remedies in nearly all cultures [1]. Nature provides an endless supply of novel phytochemicals, which are referred to as natural products (NPs), and natural product drug development is a difficult task for developing new leads [2]. Traditional medicines (TMs) are valuable because they use natural products; for example, Ayurveda, Kampo, traditional Chinese medicine (TCM), traditional Korean medicine (TKM) and Unani use natural products and have been practiced for thousands of years, blossoming into well-regulated medical systems [3]. As time passed and medication progressed, synthetic drugs, such as enoxaparin, aspirin, warfarin, ibuprofen, naproxen, clopidogrel and diclofenac, became available over the counter and were linked to mild (headaches, back pain) to severe side effects (difficulty breathing, excessive bleeding, and hemorrhage) [4]. There are no doubts that the use of natural products has markedly improved certain forms of cancer, diabetes, hypertension, pain, memory deficit, Alzheimer’s disease (AD), and migraine [5], and their further use should be continued in order to meet the urgent need for effective drugs to treat human diseases [6].
Coniferous plants, such as plants belonging to the Taxus, Cupressus, Picea, Pinus, Cedrus, Araucaria genera, are found worldwide and have shown several beneficial activities against diseases, highlighting the importance of conifers in drug development [7]. Conifers are woody, have needle-shaped single-veined leaves, and consist of male and female unisexual cones with bract scales [8]. They comprise eight families (Pinaceae, Araucariaceae, Cupressaceae, Podocarpaceae, Cephalotaxaceae, Taxaceae, Phyllocladaceae, Sciadopityaceae), 70 genera, and 630 species [9]. A number of genera include a vast number of species, such as Pinus (110), Podocarpus (105), Juniperus (55), Abies (50), Picea (35), Dacrydium (21), Taxodium (29) Pseudotsuga (22), Agathis (22), Araucaria (19), and Taxus (19), whereas there are some genera which contain a lower number of species, including Larix (10), Cedrus (4), Torreya (6) and Cryptomeria (1) [10]. They can be found in abundance in tropical lowland and submontane forests (Figure 1).
They contain secondary metabolites that combat pathogens and activate the plant’s defense mechanism [12]. The three major phytochemical groups, viz. terpenoids (resin acids and terpenes), alkaloids (piperidines) and polyphenols (phenolic acids, flavonoids, proanthocyanidins, lignans, acetophenones, and stilbenes) [13], present in the species of conifer trees are shown in Table 1, and their phytochemical compounds’ structures are shown in Figure 2. It is very important to understand the evolutionary pathway of Gymnosperms, in accordance with Sporne’s proposal, wherein the conifers represent the core, and the teachings that we can receive from it, comparing the morphological characters and their correlation with the chemical ones [14].
Phytochemical constituents present in conifers.
| Subclasss | Main Examples of Each Class | Conifer spp. | References |
|---|---|---|---|
| Terpenes | |||
| Monoterpenes | β-myrcene, α-pinene, limonene, α-terpinene, thujone, camphene, β-pinene, thujole, Δ-3-carene, phellandrene | Pinus roxburghii, P. pinea, P. wallichiana, P. pinaster, P.sylvestris, P. gerardiana, P. nigra, P. radiata, Thuja occidentalis, Abies alba, Picea abies, Metasequoia glyptostroboides | [12,15,16,17] |
| Sesquiterpenes | Laurenobiolide, farnesene, inulicin, vernodalin, 3H-benzofuaran-2-one, 4-methyl-3-methoxy-3H-benzofuaran-2-one, 4,9(α)-dihydroxynardosin-6-en, delta-cadinene, alpha-humulene, beta-cedrene, trans-caryophyllene, cubenol | P. mariana, Juniperus foetidissima, A. alba, P. abies, M. glyptostroboides, J. phoenicea, P. roxburghii | [8,12,18,19,20] |
| Diterpenes | Paclitaxel, 10-deacetylbaccatin III, tasumatrol B, taxodal, sandaracopimaric acid, taxodione, xanthoperol, andrographolide, gibberellin A8, 7α-hydroxysandaracopimaric acid, gibberellin A12, gibberellin A12 aldehyde, gibberellin A15, 14α-hydroxyisopimaric acid, 12-hydroxydehydroabietic acid, gibberellin A19, gibberellin A9, carnosol, lathyrol, E-communic acid, 15-hydroxy-8(17),13(E)-labdadiene-19-carboxilic acid, holophyllin A, holophyllin D, sugiol, ferruginol | Taxus brevifolia, T. baccata, T. globosa, T. distichum, P. mariana, J. taxifolia, M. glyptostroboides, A. holophylla, J. excelsa, J. communis, J. excelsa, J. communis | [18,19,21,22,23,24,25,26,27] |
| Nitrogen Compounds | |||
| Alkaloids | Vellosimine, 1,6-dehydropinidine, cis-pinidine, 1,6-dehydropinidinone, epipinidinone, cis-pinidinol, trans-pinidine, euphococcinine, α-pipecoline 1, (−)-pinidine | P. mariana, P. abies, P. sabiniana, P. torreyana, | [13,18,28] |
| Lignans | Lariciıesinol, taxiresinol, 3’-demethylisolariciresino1-9’-hydroxyisopropylethe, isolariciresinol, deoxypodophyllotoxin, (−)-secoisolariciresinol, 3, 3-demethylisolariciresinol, isotaxiresinol 2, α-conidendrin, (+)-pinoresinol, (−)-matairesinol, arctiin, dibenzylbutyrolactol, (−)-wikstromol, (−)-traxillagenin, (−)-arctigenin, traxillaside, 4′-deme-thyltraxillagenin, [(2R,3R)-2-(4′’-hydroxy-3′’-methoxybenzyl)-3-(4′-hydroxy-3′,5′dimethoxybenzyl)-butyrolactone] | T. baccata, J. taxifolia, J. sabina, J. virginiana, J. virginiana, P. roxburghii, Cedrus deodara, T. nucifera | [29,30,31,32,33,34,35] |
| Polyphenols: Flavonoids | |||
| Flavanonols | Taxifolin, cedeodarin | C. deodara, L. simbraca, P. roxburghii, P. mariana, P. abies, A. pindrow, A. excelsa; P. pinea, P. halepensis, P. pinaster, P. gerardiana | [33,36,37,38,39,40] |
| Flavones | Pilosanol B, luteolin, apigenin, apigenin 6-C-b-glucopyranoside | P. mariana, A. excelsa, P. abies, P. sylvestris, P. menziesii, P. menziesii, J. communis, A. angustifolia, L. deciduas | [18,38,39,41,42,43] |
| Biflavones | Bilobetin, cupressuflavone II-7-O-methyl-robustaflavone | T. wallichiana, C. macrocarpa, A. angustifolia | [43,44,45,46] |
| Flavonols | Quercetin, dihydroquercetin, rutin, kaempferol, dihydrokaempferol | J. communis, J. oxycedrus, P. gerardiana, P. roxburghii, P. wallichiana, A. angustifolia, P. abies, L. deciduas, P. sylvestris, P. menziesii, M. glyptostroboides, J. excelsa, P. mariana, J. foetidissima | [18,33,41,42,43,47,48,49,50] |
| Flavan-3-ols | Monomers: (−)-epicatechin, (−)-epicatechin-3-gallate, (+)-catechin, sennidin A, (−)-epigallocatechin, | P. pinaster, P. pinea, P. halepensis, P. roxburghii, P. wallichiana, P. gerardiana, J. foetidissima, A. angustifolia, P. abies, L. deciduas, P. sylvestris, J. communis, P. menziesii, J. oxycedrus, M. glyptostroboides, J. excelsa | [18,33,39,40,41,43,47,48,49,50] |
| Polymers: Procyanidin B1, B2, procyanidin A2, | P. halepensis, P. pinea, P. pinaster | [40] | |
| Phenolic acids | |||
| Benzoic acids | p-hydroxybenzoic acid, 2,5-dihydroxobenzoic acid, gallic acid, 4-hydroxybenzoic acid, protocatechuic acid, ellagic acid | P. abies, L. deciduas, P. sylvestris, P. menziesii, P. kesiya, J. communis, A. excelsa, P. roxburghii, P. wallichiana, P. gerardiana, L. deciduas, J. communis | [33,38,41] |
| Hydroxycinnamic acid | Caffeic acid, t-cinnamic Acid, p-coumaric acid, vanillic acid, ferulic acid, salicylic acid, sinapic acid, syringic acid, chlorogenic acid, 5-caffeoylquinic acid, caffeic acid 4-O-glucoside | P. abies, L. deciduas, P. sylvestris, T. baccata, P. mariana, P. pinaster, P. kesiya, L. deciduas, J. communis, P. menziesii, M. glyptostroboides | [18,21,39,41,42,49] |
| Stilbenes | trans-resveratrol, resveratrol, trans-pinosylvin, cis-stilbenes, pinosylvin, dihydro-monomethyl, trans-stilbenes, trans-piceatannol, trans-piceid, trans-isorhapontin, trans-isorhapontigenin, phenanthrenes, astringin, trans-astringin | P. mariana, P. abies, J. communis, P. pinaster, P. sylvestris, P. strobes, P. roxburghii, P. wallichiana, P. gerardiana, P. merkusii | [8,18,39,51,52,53,54,55,56,57] |
It is also important to keep in mind the strong tendency towards adaptation, certainly not comparable with that of the subsequent Angiosperms, of which the dominance of the Araucaceae in the southern part of South America is a shining example [58]. Once again, it appears evident that the climatic situation constitutes the determining factor in the evolutionary path, as evidenced by the residual dominance of the conifers in the environments suited to them. There is therefore a lot to explore relating to conifers, and it is useful to develop studies entirely dedicated to individual genera [59].
From the chemotaxonomic point of view, it is necessary to highlight how difficult it is to study the chemistry of conifers due to the lack of easily usable markers [60]. In fact, resin and phenolic compounds, including tannins, have proved, due to their complicated composition and wide variability, difficult to study and not suitable for deducing clear considerations from them. First of all, we must not forget the unsuccessful attempts, the once well-developed branches that are now essentially exhausted, of which Ginkgo is a sensational example, to which we can add the genus Taxus [61]. It is no coincidence that these species are now a source of drugs of great therapeutic importance. It is therefore possible that there is still a lot to investigate and study on the chemistry of conifers. A starting point is represented by the collection of the current scientific knowledge recorded so far and the possible use of these data in the light of the most recent interpretations and possible therapeutically interesting utilizations. In this sense, the main focus of this review is to emphasize conifers’ phytochemical compounds with a broad range of applications and as a source of molecules for drug development.
2. Conifers Phytochemicals Components
2.1. Terpenes
Terpenes are isoprenoids not containing nitrogen and sulfur and seem to be the main and largest group of natural phytochemicals group in conifers [12]. The terpenoids can be classified as C5 (hemiterpenes), C15 (sesquiterpenes), C20 (diterpenes), C10 (monoterpenes), C25 (sesterpenes), C40 (tetraterpenes), C40 (polyterpenes), and C30 (triterpenes) on the basis of C5 units [62]. Table 1 represents the most common mono-, sesqui- and diterpenes present in conifers. In particular, monoterpenes have been extensively studied, especially for their antiviral properties. Further, Porres-Martínez et al. (2016) reported their biological activities, including the anti-inflammatory, anticancer, antioxidant, and neuroprotective effects [63]. However, taxol diterpene derived from Taxus spp. have potential against malaria and cancer [62]. Sesquiterpenes have antiseptic, antimicrobial and disinfectant properties [64]. Kopaczyk et al. (2020) showed that the antioxidant activity of terpenes can prevail over oxidative stress aggravated by internal and external stimuli [12].
2.2. Alkaloids
There are several classes of alkaloids which are classified on the basis of the heterocyclic ring system and biosynthetic precursor which are of great interest. The alkaloids comprise quinolizidines, indoles, tropanes, pyrrolidines, pyrrolizidines, imidazoles, piperidines and isoquinoline purines [65]. There are numerous studies on the biological activity and medicinal uses of alkaloids [66]. In addition, alkaloids have been shown to have antitumor, anti-hyperglycemic and antibacterial activities [13]. Virjamo et al. (2020) reported that among the piperidine compounds of P. abies, only 1,6-dehydropinidine exhibited antibacterial effects by using a larger number of strains, whereas cis-pinidine was revealed to be toxic for vertebrates, which may only act in defense against herbivores [13].
2.3. Polyphenols
Polyphenols are of major relevance and perform a range of functions from skeletal constituents in various tissues to pigmentation in many plant organs [67]. They act as natural antioxidants, being able to inhibit lipid peroxidation, carcinogenesis, antimicrobial activity, direct capillary constrictive action, phytohormones, and have also the ability to stabilize ascorbic acid [68]. Flavonoids (isoflavones, flavonols, flavanonols, flavones, tannins, flavanones, anthocyanidins), stilbenes (resveratrol), phenolic acids (hydroxybenzoic and hydroxycinnamic acids), lignans, can all be found in plants [69]. Polyphenols, especially flavonoids, such as rutin, quercetin, apigenin, and epicatechin, are widely found in conifers. The genera Araucaria, Pinus, Cedrus, etc. are reported for their antimicrobial, anticancer, antidiabetic, neuroprotective [43] and anti-inflammatory properties and can be used in the treatment of neurodegenerative diseases, as well as being helpful in reducing αβ toxicity and neuronal dysfunction [70].
2.3.1. Flavonoids
Flavonoids are the most abundant phenol group in nature, present in a wide range of conifers [71]. Flavonoids have a central three-ring structure, but the different subclasses vary due to the centrally located heterocyclic ring structure (C-ring), which connects the two benzene rings [72]. To date, more than 6000 flavonoids have been recorded in several studies from plants. Flavonoids are aglycones in their basic structure, but most of them are glycosides in plants [73]. The subclasses of flavonoids found in the leaves, barks and seeds of conifers are represented in Table 1.
2.3.2. Lignans
Lignans are phenylpropanoids dimers made up of two coniferyl or sinapyl alcohol units bound together at the tails [74]. Isolariciresinol, taxiresinol, lariciresinol, pinoresinol, and their glycosides are examples of such compounds. There is a growing interest in lignans, especially because of their chemotherapeutic ability [75]. The most commonly present lignin compounds in conifer spp. are shown in Table 1.
2.3.3. Stilbenes
Stilbenes are produced by a number of conifer species, including Pinus sylvestris and Picea abies. Briefly, stilbenes are phenolic compounds with a heterologous bridge connecting two aromatic rings [76]. Many other compounds, such as trans-pinosylvin, cis-stilbene, resveratrol and piceatannol, have been isolated from the barks of conifer species (Table 1). For stilbenes, excellent antimicrobial effects have been reported [71].
2.3.4. Tannins
Tannins are polyphenolic compounds that can be in a wide range of plants. Tannins are colored pigments, astringent and are characterized by a bitter taste [77]. Tannin-rich conifer bark extracts have antimicrobial properties and high potential in preventing lipids from oxidation in the liposome model [78]. As a result, the tannins can be divided into four main classes based on their structural characteristics: gallotannins, complex tannins, ellagitannins and condensed tannins [79]. Condensed tannins (CTs), also well-known as proanthocyanidins, are prevalent in P. abies and P. sylvestris tree bark [77]. Condensed tannins are considered as polymers or oligomers of flavan3-ol units connected by C-C bonds that are hydrolysis resistant [80]. Procyanidins (PCs) and prodelphinidins (PDs) are the most popular PAs. Catechin and other epicatechin units make up PCs. Epigallocatechin units make up PDs [81].
Tannins exhibit antioxidant activity through various pathways, including free radical scavenging, transition metal chelation, and inhibition of pro-oxidative enzymes [82], besides having the capability to bind and form complexes with proteins and other compounds, and being responsible for their biological activity [83]. Tannins also act as antimicrobial agents, inhibiting extracellular microbial enzymes, depriving microbial growth substrates, and exerting a direct action on microbial metabolism, such as the denaturation of cell membrane proteins [84]. In the food industry, they could be used as functional coatings, adhesives, preservatives and as flavor compounds [71]. In a study, pine and spruce bark-derived PA-rich extracts revealed good potential for use in the food industry to develop preservative agents and to prevent lipid peroxidation in food items containing fatty-acids [78].
3. Traditional Medicinal Uses
Since prehistoric times, coniferous plants have been used as a medicinal source. Plant-based research has received more attention in recent years, and the literature supports the possible use of medicinal plants in conventional processes [85]. T. orientalis leaves and stems are utilized in traditional medicine to cure nervous system disorders, insomnia, heart palpitations, hemorrhage and fever. Fresh cedar leaves steeped for seven days in a 60% alcohol solution are often used by traditional Chinese physicians to encourage hair growth [86]. Cupressus spp. leaves, cones, stem bark have also been revealed to be useful in the treatment of hemorrhoids, bleeding varicose veins, asthma cough, spasms, diarrhea, rheumatism, common colds, piles, urinary tract ailments and vaginal discharge [7]. Different parts of the Pinus spp. bark, leaf, cone, and resin are also prescribed to treat cold-influenza, cough, tuberculosis, and bronchitis as a diaphoretic, rubefacient, antiseptic, diuretic, stimulant and febrifuge, while resin is also used in wound healing and injury [87]. The extract from Juniperus spp. leaves, berries and bark has also been used for the treatment of chronic eczema, hyperglycemia, obesity, tuberculosis, bronchitis, and pneumonia. The female cones, wood and leaves of J. foetidissima, J. communis and J. excelsa are used as a tonic for gout and rheumatism, a carminative, a diuretic, a treatment for urinary tract infection and stomach ache, an expectorant, a stimulant, an emmenagogue, and a treatment for the common cold [7].
Different parts of Taxus spp. have precise ethnomedicinal uses; for example, the leaves’ juice is used to cure cancer and bronchitis; bark juice and other parts, such as the leaf, are used for asthma and bronchitis, while trunk oil and cones are used to treat sheep diseases, bad breath, halitosis, inflammatory diseases of the lower urinary tract, renal stones, urinary infection, rheumatism dyspeptic complaints, hemorrhoids and cancer [7,88], and powdered dried leaves are considered to be effective in epilepsy, asthma, headache, diarrhea, bronchitis and hiccoughs [89]. A decoction developed from the bark is used to relieve pain from the muscles, knees, and rheumatoid arthritis, whereas a decoction made from the leaves is used to treat liver issues [90].
4. Conifers Extracts Rich in Phytochemical with Putative Health Effects
4.1. Oxidative Stress
The role of oxidative stress in the progression of degenerative ageing is well understood. Diabetes mellitus, coronary heart disease, cancer, inflammation, stroke, neurological conditions (e.g., AD), and ageing have all been linked to reactive oxygen species (ROS) generation [49]. Both enzymatic and non-enzymatic reactions are involved in the synthesis of ROS. ROS are known to be generated by enzymatic reactions present in many cell processes, including the respiratory chain system, prostaglandin synthesis and phagocytosis [91]. All ROS are produced through enzymatic action, including NADPH oxidase, xanthine oxidase and peroxidase in many cell processes, in whom the superoxide radical (O2●−) is generated [92]. Different ROS, formed during enzymatic reactions and with the action of enzymes (amino acid oxidase and xanthine oxidase), include hypochlorous acid (HOCl), hydrogen peroxide (H2O2), peroxynitrite (ONOO-), and hydroxyl radicals (OH●) [93]. The “Fenton reaction” between O2− and H2O2 takes place in the presence of Fe2+ or Cu+, which work as catalysts, producing OH, the most reactive free radical species [94]. The production of ROS has been related to non-enzymatic interactions between oxygen and organic compounds, as well as when cells are in contact with ionizing radiation during mitochondrial respiration [94,95]. Extensive research is currently needed to discover phytochemical compounds with the ability to boost the immune system and reduce oxidative stress [96]. The quest for new antioxidant molecules is a crucial part of promoting healthy ageing and combating oxidative stress [93]. Flavonoids, phenolic acids, vitamins and carotenoids are examples of natural compounds with antioxidant potential that have antagonistic effects on degenerative and inflammatory processes throughout the body, have beneficial effects on the immune and digestive systems, prevent ROS-related chronic problems and improve the overall quality of life, as shown in Figure 3 [88].
4.2. Synergism between ROS and other Diseases
The overproduction of ROS has been linked to a variety of chronic diseases, including cardiovascular, inflammatory and neurodegenerative diseases, and even cancer. The following sections explain on the relationship between ROS and chronic diseases.
4.2.1. Antioxidant Activity
In chronic obstructive pulmonary diseases (COPD), ROS play an important role [97]. The bark, wood, needle, and cone extracts of the Pinaceae family are high in polyphenolic compounds (Pycnogenol), primarily procyanidins, stilbenes, tannins and phenolic acids, and have significant antioxidant activity against ROS [98]. The antioxidant activity of conifer extracts has been confirmed by DPPH, FRAP and reducing power assays [51].
Flavonoids’ ability to scavenge free radicals can protect the human body from oxidative damage, which accelerates the ageing process [99]. Pycnogenol®, a polyphenol-rich compound extracted from the bark of P. pinaster, P. glauca, and P. mariana, has shown the ability to boost plasma antioxidant capacity and ameliorate pulmonary function and asthma traits [51,100]. In a study by Senthilmohan et al. (2003), 6–12 weeks of supplementation of Enzogenol®, and proanthocyanidin-rich flavonoid extracted from Pinus radiata bark in combination with vitamin C reduced DNA and protein oxidative damage in 55–75-year-old people [101]. In vivo studies have reported that the intake of quercetin alone did not protect DNA, but the combination of flavonoids (quercetin and myricetin) and isoflavonoids provides protection against DNA damage [102]. It has been found that the stilbenoid component resveratrol and piceatannol obtained from conifer spp. have more potent biological activities, namely as antioxidants [103]. Terpenoids and phenolic compounds, such as pinene, lycopene, camphene, gallocatechin, lutein, limonene and catechin found in the extract of conifer bark and needles have also been reported for their antioxidant potential by DPPH, FRAP, H2O2, ABTS assays, as shown in Table 2 [104].
4.2.2. Anti-Inflammatory Activity
When contagious microorganisms such as fungi, bacteria and viruses come into contact with the body, they remain in specific tissues and flow into the bloodstream, causing inflammation [105]. This also occurs as an end result of tissue damage, cancer, cell death, degeneration and ischemia [106,107,108]. In most cases, both the innate and adaptive immune responses are responsible for inflammation development [109]. The primary protection against invading foreign microbodies and cancer cells is the innate immune system, which involves macrophages, dendritic cells, and mast cells [105]. In the adaptive immune system, specialized cells (B and T cells) remove foreign pathogens and cancer cells by generating specific receptors and antibodies [110]. Cytokines such as interleukins, interferons, tumor necrosis factor, eicosanoids (leukotrienes and prostaglandins), modulatory inflammation-transcription nuclear factor (NF-ĸB) and chemokines (monocyte chemoattractant protein 1), are the inflammatory mediators and cellular pathways that have been extensively studied in relation to human pathological conditions [111]. Tumor necrosis factor-α (TNF) is a pro-inflammatory cytokine that is secreted by a variety of cells and has a variety of cellular effects [112]. It has also been linked to a variety of human illnesses, including cancer, mental and skin disorders, immune and inflammatory diseases. IL-1 is another cytokine that primarily has a pro-inflammatory effect [113]. It raises the levels of pro-inflammatory cytokines, including IL-1, TNF and IL-6 [114]. On the other hand, IL-1 has been linked to anti-inflammatory properties. Likewise, IL-1α and IL-6 originating from activated mast cells in the innate immune response also boost acute phase protein synthesis and thus show some anti-inflammatory effects [115]. The cytokine family members, including IL-12, IL-27, IL-23 and IL-35, function as a pro- and anti-inflammatory response [111,116,117]. On the other hand, IL-10 has been recognized as an effective anti-inflammatory cytokine, and helps in preventing several pro-inflammatory mediators from further action [118]. It protects tissue from homeostasis, defends against injury and damage caused by an overactive inflammatory response [118,119,120]. TNF-α accelerates PGE2 synthesis changes caused by edema and the flow of blood [46]. The extraction of plant materials is the first step in deciding the plant biological activities. The is a high probability of synergism between bioactive components when a whole extract is used, which could be lost if each and every component is isolated [121]. This form of synergism has been documented in numerous medical studies, generally for anti-inflammatory function [105]. There are different types of extraction and separation processes, such as:
1. Soxhlet extraction: The Soxhlet extraction method is a more efficient extraction method with high extraction yield and requires less solvent and time. This method requires electricity and solvents such as methanol, petroleum ether, and acetonitrile for the extraction process. However, sometimes high temperature and long extraction time enhance the possibility of thermal degradation and the loss of bioactive compound fraction activity [122].
2. Percolation: Extraction yield is better in percolation than maceration; in this process, pre-soaked plant material is added to a container, which allows the constantly controlled removal of the extract via a valve at the bottom and adding fresh solvent from the top.
3. Maceration: Maceration is carried out at room temperature by soaking the material with the solvent with eventual stirring. It has the advantage of moderate extraction conditions but suffers from high solvent consumption, long extraction times and low extraction yields. It could be used for the extraction of thermo labile components.
4. Ultrasound-assisted extraction: In UAE, the plant material, usually in a glass container, is covered by the extraction solvent and put into an ultrasonic bath. It decreases extraction time and improves extraction yields due to mechanical stress, which induces cavitation and cellular breakdown, and has gained increasing popularity [123]. For the isolation of extract from the solvent, the distillation process and many evaporators are used. After isolation to concentrate the extract, many researchers used a rotary evaporator, a normal air-drying process and distillation methods. Generally, to separate different solvent extracts, a separatory funnel is required [124].
Anti-inflammation is one of the main recorded effects of conifer phytochemicals among the numerous biological activities that have been studied so far. Table 3 reported the anti-inflammatory effect of conifer phytochemicals in in vivo and in vitro models.
Cupressuflavone (CUF) isolated from C. macrocarpa has the ability to reduce the levels of several cytokines, including IL-1b, IL-6, TNF-α and PGE2, in plasma dose-dependently, and thus acts as an anti-inflammatory agent [46]. Triterpenoids and abietane type’s compounds extracted from Abies chensiensis show anti-inflammatory effects against NO production in RAW 264.7 macrophage cells [125]. It has been found that tasumatrol, deacetylbaccatin, paclitaxel and many other terpenoids extracted from Taxus spp. are effective in the anti-inflammatory process initiated through the carrageenan and cotton pellets induced edema model [21,22]. Kyung-Jae Cha. (2016) reported that in atopic dermatitis, the Picea wilsonii mast extract is useful and potent only in the inhibition of the production of the inflammatory cytokines IL-6, MCP-1 and IL-13, without significant change in IL-8 production induced in human adult low-calcium high-temperature (HaCaT) cell lines [115]. T. occidentalis mother tincture-containing terpenoids (thujone), polyphenols and flavanoids have potential in reducing ulcerative colitis inflammation in the mouse intestine and rectum by decreasing the stimulation of the pro-inflammatory cytokines IL6 and TNF-α induced by 2,4,6-trinitrobenzenesulfonic acid (TNBS) [126]. THP-1 cell adhesion to TNF was suppressed by enzogenol at a concentration of 5–25 g/mL onto TNF-α-activated human umbilical vein endothelial cells (HUVEC) by reducing integrin β2 induction and inhibiting monocyte trans-endothelial migration [127]. The anti-inflammatory and platelet-inhibitory effects of pycnozenol, extracted from Pinus maritime bark extract, inhibited the activity of cyclooxygenase (COX)-1 and COX-2 present in human plasma [128]. Inflammation has been attributed to cancer and neurodegenerative diseases [46].
4.2.3. Anticancer Activity
According to the report by the World Health Organization, cancer was a major cause of death in 2018, with a death rate of 9.6 million people [129]. Hippocrates, before 370 B.C., coined the word “cancer” to describe carcinoma tumors [130]. On the basis of evidence, bone cancer was identified in Ancient Egyptian mummies in around 1600 B.C., and cancer of the breast was identified in 1500 B.C., although there is no record of a cure for cancer [131]. Giovanni’s research laid the foundation for scientific cancer techniques in 1761, when he performed the first autopsies on dead human bodies to determine the connection between a patient’s disease and their death, as well as pathologic studies [132]. Cancer has been identified as the chief matter of public health concern around the world [133]. Surgery, radiotherapy, and chemotherapy are some of the conventional cancer treatments [134,135]. On the other hand, despite the use of a variety of synthetic drugs for cancer treatment and the successful completion of different management schedules, current therapies are not able to achieve the desired results, as tumor relapse and metastasis are common [136]. Nature contains various chemicals and pharmacologically active substances which act as anticancer drugs [137]. Recently, many of the phytochemicals and synthetic analogs, such as HS-1793 (resveratrol), have been identified as inhibiting the growth of cells and inducing apoptotic cell death, helping to cure cancer [138]. While only a few phytochemical compounds obtained from natural products have been developed into clinically active drugs, their bioactive components may be used as a basis for the development of more successful analogues and prodrugs using chemical techniques such as metabolomics, complete or combinatorial fabrication, and biosynthetic pathway modification [139]. Many phytochemical compounds are highly efficient in inducing apoptosis and cytotoxicity by modulating different MAPK andAKT/PI3K pathways, and suppress cancer cells line invasion and migration potential along with the stimulation of senescence phenotype, regulation of Bax or p53 genes, cell cycle arrest and modulation of IL-8, IFN-γ, TNF, IL-6 [140]. Many of the compounds derived from conifers’ bark and leaves act as antitumor drugs, such as paclitaxel (PTX) (trade name Pycnogenol® and Taxol®), a diterpene found in the crude extract of P. pinaster and Taxus brevifolia bark [141]. Paclitaxel, as well as its analogues docetaxel (taxoteres) and jevtanas (cabazitaxel), are examples of chemotherapeutic synthetic analogues derivative from plants that have been formulated and validated clinically [139]. By binding microtubules, PTX and other microtubule-targeting agents (MTAs) induce cellular death [142]. Microtubules are tubulin heterodimers that play a role in disease and perform numerous cellular functions including transport, force production in cell division, and structural support [143]. During the G2 phase of the cell cycle, tubulin is produced, and microtubules are assembled. Microtubule stabilizing agents, such as PTX, bind to α/β tubulin in order to disassemble microtubules. As a result, they cause cell death and are used as an anti-cancer agent [144]. In general, cells exposed to PTX are stuck in the G2/M phase, resulting in death due to failure to move through the cell cycle [145,146]. Recently, a study published in 2017 found that pycnogenol and PTX at doses of 20 g/mL and 0.5 μM cause DNA and mitochondrial damage in cancer breast cell line (MDA-MB) in 24 h, and concluded that it is possibly a target drug for cancer treatment through DNA and mitochondrial damage mechanisms [141]. From different conifer species crude extracts, the anticancer activities on different cancer cell lines are summarized in Table 4.
Antioxidant capacity of extracts obtained from different conifer spp.
| Conifer spp. | Part Used | Compounds | Nature of Extract | Radical Scavenging Assay | Dose/Concentration | Main Effects | References |
|---|---|---|---|---|---|---|---|
| Aurocaria cookii | Leaves | Phenolic compounds | Methanol, chloroform, petroleum ether | DPPH | 1000 μg/mL | Methanol extract shows the best antioxidant activity with 63% inhibition, higher than the other two compounds | [147] |
| A. excelsa | Needle | Flavanoids | Methanol | DPPH | 50–72.5 μg/mL | Methanol/water extract shows antioxidant activity | [38] |
| C. deodara | Heart wood | Tannins, flavonoids, and phenolic compounds | Water/alcohol | DPPH, superoxide radical-scavenging activity, ABTS | DPPH-IC50 (μg/mL): 61.89 (water extract), |
DPPH radical-scavenging activity and the reducing power of C. deodara were potent in water and alcohol extract | [148] |
| C. japonica | All parts | Phenolic compounds | Methanol | ORAC, |
4.09–7.64 TE/mg |
The methanol extracts from each part of C. japonica except for pollen showed strong activities in the bioactivity assays. | [149] |
| J. communis | Berry | Flavanoids (quercetin rutin, |
Alcohol/Water | DPPH | EC50 1.42 mg/mL against standard Ascorbic acidEC50 value of 0.365 mg/mL | The antioxidant activity was confirmed as 81.63 ± 0.38% by the DPPH assay. | [42] |
| L. laricina | Bark | Phenolic compounds | Ethanol/Water | ORAC | IC50 0.878 μg/mL. | Bark extract of LL shows significant antioxidant activity | [51] |
| Metasequoia glyptostroboides | Cone | Terpenoid | Ethyl acetate | DPPH, NO, superoxide, and H2O2 | 5–250 μg /mL | Sugiol derived from cone extract show good antioxidant activity—78.38, 72.42, 74.45 and 85.04%, respectively. | [26] |
| Picea abies | Bark | Atilbenoids | Ethanol/Water | DPPH | 49.74 μg/mL | UVA-induced modification of the stilbene-rich inner bark extracts increased the antioxidant activity as UVA irradiation decreased the capacity of the extracts to prevent lipid oxidation in the liposome system method | [53] |
| P. smithiana | Leaves | Phenolic compounds | Methanol | DPPH | IC50 (μg/mL)- | Results of the DPPH radical scavenging activity and FRAP study determine that methanol extracts of leaf displayed the highest antiradical efficiency | [150] |
| 228 | |||||||
| FRAP | 494 | ||||||
| Reducing Power assay | 978 | ||||||
| Pinus gerardiana | Bark | Phenolic compounds | Ethanol | DPPH | IC50 value μg/mL | P. gerardiana shows promising H2O2 radical scavenging activity | [104] |
| 102.8 | |||||||
| H2O2 | 81.83 | ||||||
| NO2 | 109.2 | ||||||
| P. halepensis | Bark | Phenolic compounds | Ethanol/Water | IC50 (μg/mL). Ethanol and the water | Ethanol and water extract of bark exhibited significant free radical neutralization capacities, at conc. 0.5–8 μg/mL | [151] | |
| DPPH | 3.28, 3.26 | ||||||
| ABTS | 3.1, 3.59 | ||||||
| P. pinaster | Bark | Phenolic compounds | Ethanol/Water | PB (50%) and (90%) IC50 value μg/mL | PP bark extracts formed from PB 50% (50% ethanol) have maximum (DPPH, ABTS) radical scavenging activity while FRAP shows activity with (PB 90%) | [39] | |
| DPPH | 49.74 | ||||||
| ABTS | 59.41 | ||||||
| FRAP | 101.3 | ||||||
| P. roxburghii | Bark | Phenolic compounds | Ethanol | IC50 value μg/mL | Pine extract shows significant antioxidant activity | [104] | |
| DPPH | 97.54 | ||||||
| H2O2 | 86.90 | ||||||
| NO2 | 111.38 | ||||||
| P. wallichiana | Bark | Phenolic compounds | Ethanol | IC50 (μg/mL) | Pine extract shows significant radical scavenging activity | [104] | |
| DPPH | 111.40 | ||||||
| H2O2 | 84.18 | ||||||
| NO2 | 98.5 | ||||||
| Thuja occidentalis | Leaves | Flavonoids, phenols | Methanol | DPPH, FRAP | 20–100 μg/mL | Crude extract shows significant antioxidant activity | [152] |
| T. occidentalis | Non-woody |
Polyphenol, flavonoids | Mother tincture (MT) | DPPH, ORAC, NO | 25 or 50 mg/kg | T. occidentalis mother tincture displayed 88.3% antioxidant activity by DPPH and about 78% by NO assay | [126] |
| Taxus baccata | Leaves and |
Flavonoids, phenols | Methanol | DPPH | IC50 (μg/mL) 105.41, 518.51 leaves and cones resp. | Acetone and ethyl acetate extract of leaves show good scavenging activity | [153] |
| Water | DPPH | 533.66, >1000 leaves and cones resp. | |||||
| Acetone | DPPH | 25.24, 81.43 leaves and cones resp. | |||||
| Ethyl acetate | DPPH | 29.84, 180.26 leaves and cones resp. | |||||
| Petroleum ether | DPPH | 438.92, > 1000 leaves and cones resp. | |||||
| T. wallichiana | Leaves | Terpenoids, flavonoids | IC50 values (μg/mL) | The maximum DPPH activity was observed in methanol extract (91.25%), followed by water (87.64%), ethanol (85.23%), and ethyl acetate (83.27%) at the highest concentration (700μg/ml) | [154] | ||
| Methanol | Superoxide radical | 170.30 | |||||
| DPPH | 212.00 | ||||||
| LPO | 126.09 | ||||||
| Hydroxyl radical | 82.34 | ||||||
| Ethyl acetate | Superoxide radical | 297.55 | |||||
| DPPH | 301.80 | ||||||
| LPO | 151.96 | ||||||
| Hydroxyl radical | 199.05 | ||||||
| Water | Superoxide radical | 257.00 | |||||
| DPPH | 258.29 | ||||||
| Hydroxyl radical | 175.33 | ||||||
| T. wallichiana | Leaf, stem | Polyphenols, flavanoids, terpenoids | Methanol | DPPH |
IC50 value (μg/mL.) |
DPPH and FRAP activity of TW leaves and stem extract have high antioxidant activities. | [155] |
PB-Pine bark; TW-Taxus wallichiana.
Anti-inflammatory capacity of different conifers spp.
| Conifer spp. | Part Used | Nature of Extract | Compounds | Major Method(s) of Testing | Dose. Conc | Main Effect | References |
|---|---|---|---|---|---|---|---|
| Abies chensiensis | Twigs and leaves | Ethanol | Terpenoids | Induce lipopolysaccharide to produce inflammation in RAW 264.7 macrophage cells | 0.2–50.0 μM | 4 compounds—3α-hydroxyl-8,14,22Z,24-tetraenlanosta-26,23-olide; (5R,20R)-8(14→13R)-abeo-17,13-friedo-3-oxolanosta-8,14(30),22Z,24-tetraen-26,23-olide; |
[125] |
| A. georgei | Aerial parts | Chloroform, ethyl acetate, n-butanol | Flavanoids | dimethylbenzene-induced ear oedema in mice | 200 mg/kg | AG ethyl acetate extract shows 18% inhibition against dimethylbenzene-induced ear edema in mice while carrageenin-induced paw edema in rats shows inhibition ratios 28.2% and 35.6%, after 2 and 6h, respectively. | [156] |
| Carrageenin-induced paw oedema rat | 140 mg/kg | ||||||
| A. webbiana | Leaves | Methanol/Petroleum ether extract | Flavanoids | Carrageenan-induced rat hind paw edema model in Albino mice | 400 mg/kg | Plant leaves extract possesses significant anti-inflammatory properties | [157] |
| Agathis robusta | Leaves | Methanol | Flavanoids, tannins and saponins | Heat induced hemolytic method in human red blood cell (HRBC) membrane | 400 μg/kg | Leaves extract shows good antiinflammatory activity | [158] |
| Cedrus deodara | Stem bark | Methanol | Deodarin, quercetin, taxifolin | Carrageenin-induced paw edema in Albino rat | 100 mg/kg | Anti-inflammatory activity with 43.47% inhibition | [159] |
| Cupressus macrocarpa | Leaves | Methanol | Cupressuflavone (CUF) | Carrageenan-induced paw edema model in Mice | 40, 80, and |
CUF demonstrated antiinflammatory |
[46] |
| Juniperus communis | Berry | Alcohol/Water | Flavanoids (quercetin rutin, apigenin) chlorogenic acid | Acute-dextran and kaolin subacute inflammation induced in Wistar Rat | 10 mL/kg | The antiinflammatory action of the juniper extract, administered as a microemulsion in acute-dextran model was increased when compared to kaolin subacute inflammation induced model. | [42] |
| J. oxycedrus | Berry | Ethanol, n-butanol | Flavonoids (amentoflavone, cupressuflavone, hinokiflavone, and rutin) | Carrageenan-induced hind paw edema model in mice | 100 mg/kg | Ethanol extract of Joso berries displayed remarkable inflammatory inhibition ranging between 24.5% and 23.7% at 100 mg/kg in carrageenan-induced edema model | [160] |
| J. foetidissima | Berry | Ethanol | Flavonoids (amentoflavone, cupressuflavone, hinokiflavone, and rutin) | carrageenan-induced hind paw edema model in mice | 100 mg/kg | JFB extract at a dose of 100 mg/kg. shows high antiinflammatory effect 26.9% | [160] |
| Pinus gerardiana, P. roxburghii, P. wallichiana | Bark | Ethanol | Flavanoid, tannin | against albumin denaturation, HRBC membrane stabilization assay | 2500 μg/mL | P. roxburghii extract showed highest (%) of inhibition and protection i.e 86.54 and 89.92 against albumin denaturation and HRBC membrane stabilization. However, P. wallichiana have least inhibition and protection percentage, i.e., 76.54 and 81.2% | [104] |
| Taxus baccata | Aerial parts | Methanol | Terpenoids | ear edema induced in mice | 3.2 mg/ear | T. baccata extract displayed best activity | [21] |
| T. baccata | Bark | Ethanol | Alkaloids, terpenoids, flavonoids | carrageenan-induced paw edema in Wistar Albino rat | 200 mg/kg | Percentage of inhibition is 44% at a dose of 200 mg/kg | [161] |
| T. baccata | Heart wood | Ethanol | Taxoids, lignans | carrageenan-induced hind paw edema model inS wiss albino mice | 30–100 mg/kg | TBW shows significant antinociceptive and anti-inflammatory activities | [29] |
| T. wallichiana | Bark | Methanol | Tasumatrol B, 1,13-diacetyl-10-deacetylbaccatin III (10-DAD) and 4-deacetylbaccatin III (4-DAB) | carrageenan-induced paw edema and Cotton-pellet oedema model in Wistar rats and Swiss albino mice | 20 and 40 mg/kg; 40 mg/kg | In a carrageenan-induced inflammation model, tasumatrol B at a dose of 20 mg/kg showed significant activity, while in a cotton-pellet edema model tasumatrol B was found to be highly significant at the dose of 40 mg/kg. | [22] |
| Thuja occidentalis | Non-woody branches with leaves | Mother tincture (MT) | Polyphenols, flavonoids | Administered 2,4,6-trinitrobenzenesulfonic acid to induce intrarectal colitis in mice | 25 or 50 mg/kg | MT manage to relieve intestinal inflammation experimentally induce by TNBS in 7 days. | [126] |
JFB—Juniper foetidissima berry; AG—Abies georgei; TBW—Taxus baccata heart wood.
In vivo and in vitro anticancer and cytotoxic studies of conifer extracts.
| Conifer spp. | Part Used | Nature of Extract | Compounds | In Vitro and in Vivo Model | Dose. Conc | Main Effects | References |
|---|---|---|---|---|---|---|---|
| Abies georgei | Aerial parts | Chloroform, ethyl acetate, n-butanol | Flavanoids | Human tumor cell lines-A549, QGY-7703, LOVO, 6T-CEM | 77.5, 11.1, 7.8, 32.8 μg/mL | AGC extract has potent tumour and antiproliferative effects in humor tumor cell lines | [156] |
| (Mice) S180 tumours cell lines | 100, 200 and 400 mg/kg | AGC also exhibited activity in tumour growth inhibition in a dose-dependent manner, with ratios of 46.7, 53.1 and 31.0% at doses of 100, 200 and 400 mg/kg, respectively | |||||
| Araucaria angustifolia | Female strobili | Water | Fatty acids and polyphenols | Laryngeal carcinoma HEp-2 cells | 100–500 μg/mL | AAE inhibit the activity of mitochondria complex I and induce redox stress and cytochrome c, which leads cleavage of nuclear proteins of larynx HEp-2 cancer cells | [162] |
| Cedrus deodara | Stem wood | Chloroform | Lignans (Matairesinol, dibenzylbutyrolactol, (−)-Wikstromol) | In vitro human cell lines (cervix, breast, colon, liver, CNS, prostrate) | In vitro cytotoxicity IC 50 value-Wikstromol (71.31–93.63) and Matairesinol (50.84–95.36) μg/mL | CD lignin mixture have potent to show a cytotoxic effect at the maximum in CNS and at the minimum in liver against cancer cell lines in a dose-dependent manner at 100 μg/mL from 49 to 95%. | [34] |
| Human T lymphoblast, acute lymphoblastic leukemia cell line, Molt-4 and human promyelocytic leukemia cell line (HL-60) | IC50 (μg/mL) |
AP9-cd-induced endogenous NO production leads to the generation of peroxide and disruption of mitochondrial membrane potential, leading to apoptotic pathway activation |
[163] | ||||
| In vivo swiss albino mice (K562 cells) | The lignin mixture displays anti-cancer effects by regulating annexin V binding, intracellular caspase activities and DNA fragmentation | ||||||
| C. deodara | Needle | Ethanol | Kaempferol, myricetin, isorhamnetin and quercetin | HepG2 cells | IC50 114.12 μg/mL | TFPNCD shows potent cytotoxicity by inhibiting the growth of HepG2 cells in a dose-dependent manner |
[164] |
| Cryptomeria japonica | Leaves | Methanol | Flavonoids | Albino mice of Ehrlich Ascites Carcinoma (EAC). | 100–400 μg/gm | Tumor cell count as well as the amounts of ascetic tumour cells in packed cells were significantly reduced in infected mice treated with MC | [165] |
| Juniper communis | Berry | Methanol and water | Phenolic compounds | CaCo2 and HeLa carcinoma cell lines | IC50 1300–2500 μg/mL | Methanol and water extracts of JCB show potent antiproliferative activity against cancer cell lines | [166] |
| J. taxifolia | Leaves | Chloroform | Polyphenols and lignan | human leukemia (HL-60) cells | 2.5 μg/mL | 7α-hydroxysandaracopimaric acid, a diterpenoid compound obtained from J. taxifolia leaves, shows antitumor effects on HL-60 cells | [24] |
| J. phoenicea | Aerial parts | Chloroform | Polyphenols | IC50 values (μg/mL) | It is found that JPCF disrupts cell cycle progression in the G0/G1phase and shows apoptotic, antiproliferative and necrotic effects on cancer cells lines | [20] | |
| Human lung (A549) | 34.2 | ||||||
| Breast (MCF-7) | 24.5 | ||||||
| Liver (HepG2) cancer cells | 57.6 | ||||||
| J. foetidissima | Needle | Methanol | Quercetin, rutin | Rat brain tumor (C6) cell lines | IC50 values (μg/mL) |
J. foetidissima needle extract showed significant antiproliferative activity | [50] |
| M. glyptostroboides | Leaf | Water | Polyphenols | PC12 cells | 25 μg/mL | M. glyptostroboides leaf extract shows a cytotoxic effect and prevents oxidative damage of neuronal PC12 cells, protecting them from apoptosis; it was also found to significantly inhibit the release of LDH, which may result from apoptosis or necrosis | [49] |
| Picea wilsonii | Whole plant | DMSO | ND | Human keratinocyte HaCaT cell lines | 1–3 g/mL | PwM extracts inhibit the production of MCP-1 IL-6, IL-13 and but do not inhibit IL-8 production | [115] |
| Pinus kesiya | Woody twig | Ethanol | Phenolic compounds and flavonoids | Human hepatocarcinoma (HepG2) cell lines | IC50 (μg/mL) 52.0 | PK Extract exhibited a potent cytotoxic effect in the HepG2 cell line | [167] |
| P. kesiya | Branch | Ethanol | Phenolic compounds and flavonoids | Human leukemic U937 |
IC50: 299 μg/mL | PK ethanol extract possesses anticancer activity against U937 human leukemic cells via apoptosis | [168] |
| P. merkusii | Leaves | Methanol | Phenolic compounds | MCF-7, A549, HT 1080 and HepG2 Huh-7 cancer cell lines | IC50 (μg/mL) |
PM methanol extract possesses anticancer activity against human cancer cell lines | [169] |
| T. baccata | Leaves, cones | Methanol | Phenolic compounds | HCT-116 human colon cancer and MDA-MB-231 human breast cancer cell lines | IC50 μg/mL |
Methanol extracts of leaves had better activity on HCT-116 cells than seed cone extract, with IC50 values of 14.3 for 24 h and 4.59 for 72 h. Meanwhile, extracts did not show any significant cytotoxic effects on the cancer cell lines | [153] |
| T. wallichiana | Heartwood | Methanol | Lignans 1 (taxiresinol 1) 2, 3 | colon, ovarian liver, and breast cancer cell lines | IC90 lignan 2 and 3 μg/mL |
Taxiresinol 1 shows anticancer activity against ovary, colon, liver and breast cancer cell lines, while lignans 2 and 3 were found to be most active against Caco-2 cell lines | [170] |
| T. yunnanensis | All parts | ND | α-Conidendrin | MCF-7 andMDA-MB-231 cancer cell lines | 40 μM | α-conidendrin have the potential to inhibit human breast cancer cell lines MDA-MB-231 and MCF-7, showing viability of 73 and 82%, respectively | [31] |
| P. roxburghii | Leaves | Water and ethanol | Phenolic compounds | A549 human lung cancer cell line | 111.2 and 112.7 μg/mL | PRL extract shows potent anticancer activity against cancer cell lines. | [171] |
| Taxus cuspidata | Branches and leaves | Water | Polysaccharides | MCF7 | IC50 μg/mL | Purified polysaccharides (Pe4) on HeLa cells had the highest inhibitory effect, and its IC50 value is 89.9, while (Pe1) shows the best cytotoxic capacity against cancer lines HepG2 and MCF7, with IC50 conc. 132.0 and 169.0 μg/mL, respectively | [172] |
| 169.0 | |||||||
| Hela | 89.9 | ||||||
| HepG2 | 132.0 | ||||||
| Thuja occidentalis | Leaves and non-woody branches | Mother tincture (MT) | Polyphenols including flavonoids | Caco-2 cells | 25 or 50 mg/kg | Caco-2 cells exposed to H2O2 and T. occidentalis MT proves its radical scavenging activity by reducing GSH level by 103% and 98% as compared to TNBS group; MT also managed to reduce the lipid peroxidation | [126] |
| T. occidentalis | Leaves | Ethanol | ND | Human NSCLC (A549) cell lines | IC50 μg/mL | Extract of TO shows both anticancer and antiproliferative activities against NSCLC (A549) cell lines in a dose-dependent manner. | [173] |
| 282 | |||||||
| Human normal embryonic cell lines (L-132) | 376 | ||||||
| T. occidentalis | ND | Mother tincture (MT) |
Thujone | A375 human malignant melanoma cell line | 200 μg/mL | TRF as compared with TO MT on exposure to A375 cells exhibited highly cytotoxic, apoptotic and antiproliferative effects, but TRF shows a lower growth inhibitory response towards peripheral blood mononuclear cell (normal cells) | [174] |
ND—Not determined; AGC—Abies georgei chloroform extract; AAE—Araucaria angustifolia water extract; TFPNCD—total flavonoids from the pine needles of Cedrus deodara; PRL—P. roxburghii leaves.
4.2.4. Neurodegenerative Diseases
Neurodegenerative diseases (NDs) are more common among the elderly and may even lead to death, and so are a major threat in the 21st century [175]. AD, Parkinson’s disease (PD), Huntington’s disease (HD), amyotrophic lateral sclerosis (ALS), frontotemporal dementia, and the spinocerebellar ataxias are examples of ND [176], whose main features include nitrosative/oxidative stress, mitochondrial dysfunction, aggregated proteins accumulation, synapse loss, neuro-inflammation and decreased neuronal survival [177]. The progression of ND is also affected by genetic and surrounding ecological factors [175]. Indeed, it has been stated that the appropriate mechanism behind the cause of ND is mitochondrial dynamics variation, which elevates the oxidative damage, altering the biological activity of respiratory complexes, which results in brain energy dysfunction [178]. These stimuli trigger cellular stress, which leads to the synthesis and release of brain-derived neurotrophic factor (BDNF), as well as the activation of transcription factor CREB (cAMP response element-binding protein), with consequent expression of Arc (synaptic plasticity), PGC-1 (cellular energy metabolism), and APE1 (DNA repair enzyme), as well as the activation of the tropomyosin-related kinase (Trk B) receptor family and other downstream protein kinases [179].
Neurotrophins avoid neuron degeneration by binding to and activating the Trk receptor family, which is located in the plasma membrane [177]. Neurotrophins work by binding to and activating the Trk receptor family, which is found in the plasma membrane, to prevent neuron degeneration. Since neurotrosphins bind to Trk receptors, they create a microenvironment that promotes neuron development [180]. Various intracellular signaling pathways, such as ERK and PI3k/AKT, are regulated as a result of this binding, allowing cells to survive and aiding in the recovery of neurons from neurodegeneration. Additionally to signaling pathway activation, neurotrophins support Bcl-2 gene expression, which inhibits intracellular apoptosis [180]. Thus, early diagnosis of neurodegeneration may allow for early treatment, which may help to prevent the disease from progressing further [181]. Inhibition of the N-methyl-D-aspartate (NMDA) receptor can prevent or postpone AD. The drugs memantine and namzaric, which act as antagonists for the NMDA receptor, are used to treat AD patients [182].
Bioactive molecules have been recognized for their valuable biological effects, including neuroprotective properties, such as the ability to regulate mitochondria in a way that is distinct from TMs [183]. Branco et al. (2018) found that the flavonoid-rich A. angustifolia bracts extract (AAE) has neuroprotective properties by restoring rotenone-induced mitochondrial complex I, inhibiting the formation of lipid peroxidation and neuronal ROS, and through over expression of NDUFS7 protein and NDUFV2 gene levels in human dopaminergic SH-SY5Y cells [43]. Bark extract of P. pinaster shows protective effects against oxidative hemolysis induced by H2O2, the formation of thiobarbituric acid reactive products and lipid peroxidation [184]. In addition, it prevents oxidative damage to many proteins aggregation and may lessen the risk of several NDs, such as AD, PD and HD [185]. The neuro-protective potential of various conifer spp. crude extracts is summarized in Table 5.
4.2.5. Alzheimer’s Disease (AD)
AD is a common neurodegenerative disease that affects 80% of the elderly population, accounting for about half of all dementia cases and ultimately results in death [186]. Its symptoms include failure to learn, gradual memory loss, and deterioration in behavior and neuronal function [187]. Regarding treatment, only five approved treatment options are licensed in the European Union for the treatment of AD, including rivastigmine, donepezil (cholinesterase inhibitors (ChEIs), galantamine, and memantine (NMDAR antagonist) [188]. An antimitotic agent paclitaxel widely used for the treatment of lung, ovarian and breast cancer has also been investigated as a possible treatment for AD [189]. It is mainly effective in the treatment of tauopathies, which are disorders caused by mutations in the tau protein, which is abundant in central nervous system (CNS) cells and acts by stabilizing microtubules [190]. The consumption of polyphenol-rich foods or beverages has been related to the prevention of AD in distinct studies [191]. The accumulation of amyloid-(A) in brain and leptomeningeal vessels causes cerebral amyloid angiopathy (CAA), which is also a central component of neuritic plaques in AD amyloid-(A) and has been related to the pathogenesis of two of the most common forms of dementia: AD and CAA. As a result, Aβ should be a top priority in the treatment of these diseases, which currently have no effective therapies [192]. Taxifolin, an antioxidant and anti-glycation flavonoid, reduces Aβ aggregation and its accumulation in the cerebrovascular system. In vitro studies have shown that taxifolin facilitates Aβ clearance in the brain, prevents Aβ fibril formation and CAA cognitive loss, and increases cerebral blood flow [193]. The methanol extract of P. roxburghii bark contains bioactive compounds, such as quercetin and gallic acid, which play important roles in neuroprotection by reversing mitochondrial dysfunction, free radical formation, and improving memory and cognition in rats, as well as reducing oxidative stress by improving acetylcholine levels. Furthermore, anti-AD activity has been documented in Pinus species, such as P. halepensis and P. massoniana [194]. Piceatannol, a compound derived from pine bark, has proven to be effective in preventing AD [195]. Resveratrol (RV), a stilbenoid, protects neurons from oxidative damage in a variety of ways, such as lowering lipid peroxidation and increasing intracellular antioxidant levels including antioxidant enzymes catalase (CAT), superoxide dismutase (SOD), glutathione peroxidase (GPx), and heme oxygenase 1 (HO-1) [196]. In this way, RV acts as an anti-AD agent by reducing neuroinflammation, inhibiting Aβ-plaque formation and tauopathy, and as a result inhibits neuronal death and improves memory [197]. Pycnogenol derived from P. pinaster bark has antioxidant, anti-inflammatory, and neuroprotective properties, including inhibition of amyloid-induced neuron apoptosis [198]. When the effect of pycnogenol was investigated in AD-related pathology in a β-amyloidosis mouse model, a decline in plaque numbers was found, while no changes were reported in the soluble β-amyloidosis levels, astrocytes, neurons, microglia, myelination pattern, morphology of axons and the gene expression of APP-processing enzymes [199]. Hence, it is suggested that pycnogenol has potential use in the prevention or in early stages of AD and mild cognitive impairment (MCI) [200]. Table 5 summarizes the neuroprotective potential of different conifers’ phytochemicals in AD.
4.2.6. Parkinson’s Disease
PD is second to AD in terms of the most prevalent progressive ND, with an estimated global prevalence of over 10,000,000 cases [201]. The selective loss of dopaminergic neurons in the substantia nigra pars compacta (SNpc) leads to PD. Briefly, PD occurs due to oxidative stress, dysfunction of mitochondrial complex-1, oxidative cell damage, neuronal excitotoxicity, calcium homeostasis, apoptosis, distressed energy metabolism, inflammation and protein aggregation, such as a-synuclein, apoptosis, and interaction between genetic and environmental causes [202]. Due to uncoordinated mouth and throat movements, PD causes bradykinesia, muscle rigidity, rest tremor, and the loss of postural control, as well as certain secondary symptoms, such as dementia, sialorrhea, soft voice, and trouble swallowing [203,204]. Oxidative stress generates ROS that causes oxidative damage, such as 4-hydroxynonenal (HNE), 26S proteasome and interferes with dopamine metabolism leading to PD [85]. Changes in protein ubiquitination and degradation have recently been related to dopaminergic cell death in PD [205]. Presynaptic protein α-synuclein (α-syn) influences the release of neurotransmitters from synaptic vesicles in the brain [206]. Currently, the treatment of PD includes drugs such as L-DOPA, which is catalyzed primarily by dopa decarboxylase in the brain, and some others such as ropinirole, selegiline, and rasagiline. Ropinirole has some adverse effects, including ankle oedema, vomiting, nausea, hypotension, insomnia, weight loss, hallucinations, psychosis, arrhythmia, dry mouth, nightmares, persistent diarrhea, somnolence and constipation, limiting their clinical applications [207]. As a result, the focus of rising interest in alternative treatments for ND, such as PD, has turned to natural products, which can provide alternatives due to their high effectiveness and few side effects [208]. Many plant extracts tend to stop α-syn from oligomerization and fibrillation, which is an emerging therapeutic mechanism in PD [183]. Methanol extract of J. communis at doses of 100 and 200 mg/kg was found to be effective in reducing catalepsy, enhancing locomotor activity (actophotometer), and increasing the level of reduced glutathione (GSH), protein level and muscle activity in rats [209]. In an in vitro study on Fisher F344 rats, Zhang et al. (2010) discovered that RV protect dopaminergic neurons from damage caused by MPP+, 6-OHDA, and also show efficacy against lipopolysaccharide-induced neurotoxicity by inhibiting nuclear factor kappa B (NF-κB) signaling and microglial activation [210].
4.2.7. Insomnia
Insomnia is a chronically debilitating disease that has become increasingly common, posing immense health and economic challenges for both individuals and the community [211]. Trouble falling asleep, staying asleep, fragmented sleep (repeatedly waking up at night or waking up early in the morning) are all symptoms of this condition [212]. While behavioral therapy, psychotherapy and light therapy have all been used to treat insomnia, the most common medications for insomnia are hypnotic drugs that target GABAA-benzodiazepine (BZD) receptors, such as diazepam and zolpidem [213]. However, several side effects have been identified, including cognitive impairment, resistance, headaches, nausea, and rebound insomnia [214,215]. Methanol extract of A. webbiana leaves showed potent synergistic effect in mice at dose of 100, 150, and 200 mg/kg, with sleep-inducing sedative drugs, diazepam (6 mg/kg), pentobarbitone sodium (50 mg/kg) and propylene glycol [157]. In addition, the major monoterpenoid components present in Pinus spp., α-pinene and 3-carene, have been reported to have hypnotic effects through GABAA-BZD receptors. 3-carene increases the length of sleep in mice given pentobarbital-induced sleep drugs by binding to the BZD site of the GABAA-BZD receptor α1 and ϒ2 [216].
5. Other Activities
5.1. Antidiabetic Activity
Diabetes mellitus is one of the world’s most serious health issues, with a rising prevalence and mortality rate [217]. Insufficiency in blood sugar control has significant health implications. Anti-diabetic medications are successful, but they come with unwanted side effects. Medicinal plants, on the other hand, can act as an additional reservoir of anti-diabetic agents [218]. Insulin and synthetic oral drugs hypoglycemic drugs are the most commonly used treatments for diabetes, despite the fact that they do not fully reverse the disease’s complications and have severe side effects. This is the driving force behind the search for new anti-diabetic agents [219]. After six years of treatment, sulfonylureas are expected to lose effectiveness in 44% of patients, while glucose-lowering drugs have been stated to be unable to control hyperlipidemia [220]. Nonetheless, the quest for newer antidiabetic drugs from natural sources continues due to many drawbacks associated with the use of current synthetic antidiabetic drugs [221].
Many plants have long been known to be a significant source of effective antidiabetic drugs in developing countries, especially to reduce the cost of conventional treatments [217]. Phytoconstituents, such as terpenoids, flavonoids, alkaloids, carotenoids, saponins, glycosides, which have antidiabetic effects, are now used to treat diseases such as diabetes [219,222]. Indeed, the number of people living with diabetes is rising, stoking concerns among medical professionals and the public. Despite the availability of antidiabetic medications in the market, medicinal plants are also effective [217]. The Araucaria, Cedrus, Juniperus, Pinus, Thuja, and Taxus genera have all been studied for their antidiabetic, antihyperglycemic, and hypoglycemic properties, as well as their ability to inhibit α-amylase and α-glucosidase and shown in Table 6.
In vitro experiments exhibited that the ethanol extract of P. halepensis bark had a greater inhibitory effect on the enzymes involved in diabetes (α-amylase and α-glucosidase) with IC50 values of 234.26 and 7.97 µg/mL, respectively [151]. Piceatannol is a phytochemical that has antidiabetic properties. Piceatannol, a resveratrol analogue, restores palmitic acid-induced disruption of insulin signaling and endothelial NO production in human endothelial cells by activating anti-inflammatory and antioxidant mechanisms (HO-1) [223]. According to Vallianou et al. (2013), the antihyperglycemic property of resveratrol appears by increasing the glucose transporter activity that occurs in the plasma membrane; the results indicate that the key antihyperglycemic action effects of resveratrol are due to the SIRT1 activation and AMPK (5’ AMP-activated protein kinase) [224]. RV antidiabetic activity is linked to its ability to increase AMPK and SIRT1 expression/activity in different tissues of diabetic subjects [225]. The multi-target effects of RV against diabetes were well-defined by Bagul and Banerjee, 2015, who underlined an improvement in insulin sensitivity and GLUT-4 translocation, while oxidative stress was reduced, carbohydrate-metabolizing enzymes were regulated, SIRT1 and AMPK were activated, and adipogenic genes were decreased [226]. As a result, lowering glucose levels by inhibiting enzyme activity is an effective method for treating hyperglycemia through using natural products.
5.2. Anticonvulsant Activity
Epilepsy is a neurological condition that affects people of all ages all over the world. The side effects of antiepileptic drugs and their connection to oxidative stress have prompted researchers to look for new medications that are less expensive and that have fewer side effects [227]. Several natural compounds derived from various conifer species have shown good anticonvulsant properties in animal models [228]. In India, extracts of C. deodara wood and P. roxburghii bark have historically been used to treat neurological disorders. In this analysis, the anticonvulsant activity of 3,4-bis(3,4-dimethoxyphenyl)furan-2,5-dione (BDFD) isolated from the ethanol extract of C. deodara and quercetin, chlorogenic acid, and rutin isolated from the ethanol extract of P. roxburghii bark were assessed in mice, and the results demonstrate modulation in the function of glutamate receptors by enhancing inhibitory GABA minergic neurotransmission [228,229]. Hinokiol, a neuromodulatory compound isolated from Taiwania cryptomerioides, affects NG108-15 cells and rat hippocampal CA1 neurons or neuronal ion channel activities by inhibiting voltage-gated Na(+) channels (VGSC) [230]. Lectins, normally a glycoprotein extracted from seed of A. angustifolia, had an antiseizure effect in strychnine and pentylenetetrazole-induced seizure models, revealing positive effects in the activation of glycinergic and GABAergic systems, respectively, and caused a reduction in animal movements [231].
5.3. Analgesic Activity
Analgesia/pain is an intense, ill-defined feeling triggered by a stimulus (external/internal); it is the most significant symptom that serves as an alarm signal and is mainly defensive in nature [232]. Bradykinin, tumor necrosis factor (TNF), and ILs cause analgesia by blocking the pain nerve sensitizing pathway [233]. An analgesic is a drug that relieves pain by acting on pain mechanisms in the CNS or in the peripheral nervous system (PNS) without affecting consciousness [234]. Even after new advances in pain therapies, healthcare professionals still need safe, reliable, and effective analgesic drugs to treat a variety of painful conditions, especially chronic pain. Based on its traditional medicinal uses, isolated T. wallichiana constituents are widely explored for analgesic purposes [22]. Indeed, the analgesic activity of C. deodara methanol bark extract was observed in Albino rats with acetic acid-induced writhing and found that it had a major analgesic effect, with 55.8% defense at a dose of 100 mg/kg [159]. In the acetic acid-induced writhing and hot plate model, Cupressus flavanone (CUF) demonstrated significant analgesic activity. At the three CUF doses used, 160 mg/kg in 120 min prevented PG synthesis and writhing response in mice at a rate of 25, 48, and 62%, respectively [46].
5.4. Antinociceptive Activity
Heartwood ethanol extract of T. baccata taxoids and lignin derivative compounds exhibited potent antinociceptive activity against p-benzoquinone-induced abdominal contractions in mice [29].
5.5. Antimicrobial Activity
Coniferous tree extracts are attracting intensified interest among scientific communities due to their possible applications in food, medicine, and cosmetics. Among conifers spp., various extracts have recently been identified as a significant source of bioactives with antimicrobial potential, as shown in Supplementary Materials Table S1.
Conifers’ phytochemicals demonstrating neuroprotective potential in vitro and in vivo.
| Conifers spp. | Compounds with Neuroprotective Potential | Model | Effective Concentration | Relevant Bioactivities | Reference |
|---|---|---|---|---|---|
| Abies holophylla | Holophyllin-D | C6 glioma cells | 20 μM | Diterpenes compound holophyllin D shows neuroprotective potential in C6 glioma cells by inducing nerve growth factor | [25] |
| Araucara angustifolia | Catechin, epicatechin and rutin | Rat | 10 mg/mL | AAE has antioxidant and neuroprotective properties as it decreases the TBARS levels, CAT activity and NO production in the hippocampus region of the brain in rats. | [235] |
| A. angustifolia | Catechin, epicatechin, rutin, quercetin and apigenin | human dopaminergic SH-SY5Y cells | 5 μg/mL | Decrease in the production of neuron (ROS) and lipid peroxidation. | [43] |
| A. angustifolia | Quercetin | cockroach | 200–400 μg/g | Neurotoxicity modulates the behavior of insects by altering the dopaminergic pathways, as quercetin has the ability to induce selective inhibitory actions on NMDA and GABA receptors and inhibit the enzyme acetylcholinesterase (AChE) | [236] |
| Cedrus deodara | Cedrin | PC12 cells | 0.1, 1 and 10 μM | PC12 cells injured by amyloid β1–42 can be improved by cedrin. Cedrin can reduce (ROS) overproduction, enhance the activity of SOD and decrease MDA content and inhibition of oxidative stress, improvement of mitochondrial dysfunction and suppression of apoptosis in PC12 cells | [237] |
| Metasequoia glyptostroboides | Gallic acid, rutin, myricetin, kaempferol, quercitrin, epigallocatechin, epicatechin gallate epigallocatechin gallate and caffeic acid | Neuronal PC12 cells | 2 mg/mL | The extracts effectively reduced the hydrogen peroxide-induced lipid peroxidation in neuronal PC12 cells by decreasing intracellular ROS accumulation | [49] |
| Pinus densiflora | Catechin, quercetin dehydrate, astragalin and kaempferol | Mice | 50–100 mg/kg | Catechin displayed a potential effect protecting mouse brains from oxidative damage via the improvement of the antioxidant capacities of TAC, the GSH-redox system, SOD and CAT in the hippocampus region as well as the inactivation of cytokines such as NF-kB in pyramidal cells of the hippocampal CA1 region, while PNE shows antiamnesic properties and effects in Alzheimer’s, as it attenuated the increase in serum corticosterone level and up-regulation of GR hippocampal gene expression | [238,239] |
| P. eldarica | Needle extract | Mice | 50 mg/kg | Alkanes, sterols, terpenoids, and quercetin, which is found in P. eldarica, help in inducing sleep and alter the sleep–wake cycle partly via activation of GABA receptors | [240] |
| P. massoniana | Polyprenols | Mice | 25 mg/kg | Polyprenols significantly increased T-AOC, GSHPx, damaging peroxide components from cells in order to stop the lipid peroxidation chain reaction and avoid excessive hydrolysis to form NEP, MDA, SOD activity (remove free radicals) and β-site AβPP cleaving enzyme 1 (BACE1) expression, while NOS activity, MDA concentration, NO, concentration of Aβ1-42 and PS1 were reduced | [241] |
| P. pinaster | Pycnogenol (PYC) | Mice | 20 mg/kg | In the MPTP-induced mouse model, PYC could prevent dopaminergic neurons by reducing oxidative loads, suppressing glial cell activation, and inhibiting inflammatory responses | [100,242] |
| P. roxburghii | Quercetin, rutin, gallic acid | Wistar albino | 100–300 mg/kg | Quercetin and gallic acid, both present in stem bark, have been shown to inhibit neuronal toxicity and apoptosis by reversing mitochondrial dysfunction and free radical development | [243] |
| Thuja occidentalis | Water extract | Mice | 100 mg/kg | CNS depressant activity, anticonvulsant and muscle relaxant activity | [244] |
| Torreya nucifera, | Arctigenin | Rat Cortical cells | 0.01 µM to 10.0 µM. | Arctigenin significantly attenuated glutamate-induced neurotoxicity by inhibiting the binding of [3H]-kainate to its receptors | [35] |
| T. semen | Polyphenols, flavonoids | Mice | 0–10 mg/mL | TS increased the level of total glutathiones | [245] |
T-AOC—total antioxidative capacity; GSHPx—glutathione peroxidise; SOD—super oxide dismutase; NEP—neprilysin; MDA—malondialdehyde; NO—nitric oxide, NOS—nitric oxide synthase; PS1—presenilin 1, CAT—catalase.
Antidiabetic activity of different conifer extracts.
| Conifer spp. | Part Used | Compounds | Model | Induction of Diabetes | Dose. Conc | Effects | References |
|---|---|---|---|---|---|---|---|
| Araucaria cunninghamii | Seeds | Glucomannan | Albino wistar rats | Streptozotocin | 25 and 50 mg/kg |
|
[246] |
| Cedrus deodara | Heart wood | Flavonoids | Wistar albino rat | Alloxan | 500 mg/kg |
|
[247] |
|
Juniperus
|
Berry | Flavonoids | Wistar rat | Streptozotocin | 250 mg/kg |
|
[248] |
| J. communis | NR | NR | Rat | Streptozotocin-nicotinamide | 100–200 mg/kg |
|
[249] |
| J. oxycedrus | Leaves | Linolenic acid, oleic acid | Wistar-albino rats | Streptozotocin | 500 and 1000 mg/kg doses |
|
[250] |
| Pinus gerardiana | Nut | Flavonoids | Rat | Alloxan | 250, 500, and 750 mg/kg |
|
[251] |
| P. halepensis | Bark | Phenolic compounds | Rat | Glucose | 250, 500 mg/kg |
|
[151] |
| P. pinaster | Bark | Phenolic compounds | NR | IC50 (µg/mL) at PB 70% and PB 50% |
|
[39] | |
| α-amylase | 254.2 | ||||||
| β-Glucosidase | 122.7 | ||||||
| P. pinaster | Bark | Pynogenol | Human | NR | 100 mg |
|
[252] |
| P. roxburghii | Bark | Quercetin | NR | Alpha amylase inhibitory activity | 100 μg/mL |
|
[171] |
| P. roxburghii | Bark | Quercetin | Rat | Alloxan | 100, 300 and 500 mg/kg |
|
[253] |
| Taxus cuspidata | Branches and leaves | Water | Polysaccharides Pe4 (arabinose, galactose, glucose, xylose, mannose) | NR | 10–120 μg/mL |
|
[172] |
NR—Not reported.
Conifer compounds act as antimicrobials because they have potential in degrading microbial cell walls: disruption to the cytoplasmic membrane and membrane proteins, cell leakage, cytoplasm coagulation, and proton motive force depletion are all examples of their inhibitory action [254]. The following is a list in descending order of the key bioactive compounds responsible for antimicrobial effects: ketones > alcohols > esters > hydrocarbons > aldehydes > ketones > alcohols > esters > hydrocarbons [255]. Terpenoid compounds (α-terpineol, δ--3-carene, geranyl acetate, borneol, α and β-pinene, limonene, α-terpinene, ϒ-terpinene, β-ocimene, bornyl acetate, 1,8-cineole, α-phellandrene, p-cymene, linalool, ϒ-muurolene, α-humulene, and cadinene) have been found to be responsible for antimicrobial activity [8,33]. Alkaloids, especially 1,6-dehydropinidine obtained from P. abies needle and bark, have recently been discovered to have antimicrobial activity against Streptococcus equi (MIC = 55 g/mL) [13]. Secoisolariciresinol, pinoresinol, eudesmin, lariciresinol, and lariciresinol-4-methyl ether isolated from A. araucana wood methanol extract have shown potent antibacterial and antifungal activity with a synergistic effect, enhancing their potency against bacteria and fungi [256]. Anti-herpes activity was found in hydroethanolic extract ethyl acetate (EA) and n-butanol (NB) fractions from A. angustifolia leaves, indicating that conifer spp. could have been used in folk medicine to treat viruses [45]. It has been reported that RV, piceatannol, hydroxystilbenes and isorhapontigenin are present in debarking water, a byproduct of debarking logs of P. abies, meaning that it has the potential to prevent the growth of a variety of fungi and may be used as a natural fungicide [257].
5.6. Larvicidal Activity
In recent years, there has been increased interest in secondary metabolites with potential larvicidal activity in a number of countries around the world [258]. Dengue fever, yellow fever, dengue hemorrhagic fever, malaria and chikungunya are the most severe diseases transmitted by mosquitoes. Aedes aegypti is one of the mosquito species involved in the transmission of such vector disease outbreaks [258,259]. Larvicidal activity has been documented in extracts of conifer spp. parts [260]. The mosquito control technique is determined by the larval stages (egg, larvae, pupae, and adult) of the target. Mosquito control methods include spraying chemical insecticides on adult mosquitoes or destroying mosquito larvae before they grow into adults, either by means of synthetic larvicides or by using botanical extracts as an alternative larvicide [258]. The use of these synthetic insecticides against mosquitoes creates insecticide resistance as well as multifarious problems, such as environmental pollution and poisonous hazards to human beings [261]. These plant-oriented natural products are eco-friendly in nature and are preferred for use against larvae over other synthetic insecticides [262]. Based on mortality, the ethanol extract of J. procera and T. orientalis leaves has potential against Anopheles arabiensis, A. stephensi and Culex quinquefasciatus larvae [260,263]. It also has been found that C. sempervirens petroleum ether leaves extract shows a toxic effect on Musca domestica larva and also causes a decrease in the production of eggs and fecundity, as well as inducing sterility in both males and females [264]. Ethanol extract of Pinus caribaea and P. merkusii leaves and bark exhibited the highest mortality in the larvae of A. aegypti, a vector responsible for dengue fever transmission [265].
5.7. Cardiovascular Diseases
The rate of death due to cardiovascular diseases is quite high. Several medications are available to treat cardiovascular disorders and their complications. The general public has come to recognize the use of functional foods or dietary supplements to treat cardiovascular diseases [266]. A study reported that pycnogenol supplementation regulates the circulation in blood vessels, and reduces mild hypertension, cardiovascular diseases and platelet aggregation stimulated by smoking [267]. RV protects the heart by inhibiting platelet aggregation, thromboxane A2 formation (vasodilator effect), and Cox-1 peroxidase reactions [268]. In addition, low doses of RV (such as those present in the average diet) have been shown to have cardioprotective effects [269]. Cardiovascular disorders are common in both developing and developed countries. Piceatannol is intended to help to prevent cardiovascular disorders, including arrhythmia, high cholesterol, angiogenesis, and atherosclerosis [266]. Piceatannol pretreatment decreases cardiac hypertrophy, as measured by hypertrophy marker expression levels, cross-sectional area, and heart weight/body weight ratio. It also prevents lentiviral GATA-6-induced cardiac hypertrophy [270].
6. Clinical Trials
Clinical trials using extracts from conifer species in humans are limited. Only a few studies have reported the use of conifer spp. extracts in humans for inflammation and cardiovascular issues. A randomized 10-day, double-blind clinical trial was conducted on traumatic brain injury (TBI) patients. A pycnogenol supplement (OLIGOPIN) was orally administered with an oral dose of 150 mg per day, conducted in 60 people, with 30 control (Placebo) and 30 taking the PYC supplement, and it was found that PYC is effective in reducing inflammation and oxidative stress in TBI patients by increasing the level of pro-inflammatory cytokines, e.g., IL-6, TNF-α, IL-1β, and C-reactive protein (CRP) [271]. Another pilot study with a length of 12 weeks was conducted with Enzogenol® at an oral dose of 480 mg/day in 26 healthy people aged between 55 and 75 years. Some significant results have been published, such as beneficial changes in anthropometric data, a reduction in unnecessary body fat, vascular and plasma rheological indices, with a reduction in blood pressure and cardiovascular-related problems [272]. Nowadays, many products such as supplements, gels, creams, lotions, capsules, tablets, ointments formed from conifers’ bark, and needle powder are sold commercially. Table 7 describes the main characteristics of these products.
Conifer-derived commercially available products sold on the global market.
| Plant | Part Used | Trade Name | Phytochemicals Composition | Formulation | Dose/Duration | Product |
|---|---|---|---|---|---|---|
| Pinus pinaster | Bark | Pycnogenol | Catechin, taxifolin, procyanidins, caffeic, p-hydroxybenzoic, ferulic, acids | Tablets, liquids, chewing gums, gels, ointments, capsules or lotions | 150 mg/day for 6 months | |
| P. pinaster | Bark | Oligopin | Caffeic acid, catechin, epicatechin, taxifolin and ferulic acid | Capsules | 150 mg for 10 days | |
| P. radiata | Bark | Enzogenol | Flavanoids, proanthocyanidins | Tablets | 480–960 mg/day for 5–6 months | |
| Picea abies | Needles | Ropren | Flavanoids | Tablets, capsules, lotions | 8.6 mg/kg for 28 days | |
| Taxus brevifolia | Bark | Taxol | Paclitaxel | Injections | 30 mg/m2 every 3 weeks | |
| P. massiona | Bark | Not found | Polyphenols, flavanoids, proanthocyanidins | Capsules | 1 capsule daily |
7. Phytotoxic Effects of Conifer Extract
Despite all of the advances stated so far, toxicity studies are required to know the effective doses that could be administered subsequently, as well as to depict the potential clinical signs elicited by the plant material [273]. Few toxicological studies have been reported on T. baccata, P. contorta and J. communis needles. A study was performed on a sample collected from a fatal case of a 22-year-old man, which revealed the presence of taxol A, diterpenoids such as monoacetyltaxine, and cardiotoxic compounds, such as 10-deacetylbaccatin III and taxine B. These compounds bind to calcium channels in cardiac myocytes, causing nausea, seizures, vomiting, dizziness, several cardiovascular effects, including bradycardia, and leading to ventricular tachycardia with severe ventricular arrhythmias, ventricular fibrillation and abdominal pain [274]. In another study, it was found that pine and juniper needles at an oral gavage dose of 62–245 mg/day in cattle have an abortifacient effect due to the presence of isocupressic acid in high doses [271]. Therefore, it is unsafe to feed pine and juniper needles to gravid cattle.
8. Conclusion and Future Trends
In this review, we have discussed the traditional and pharmacological uses of various conifers’ extracts against diabetes, neurological disorders, inflammation, and cancer. The phytochemical constituents present in conifer extracts are nontoxic at therapeutic levels, with polyphenolic compounds having significant biological activities. Stilbenes, terpenes, alkaloids, lignins and flavanoids, such as quercetin, rutin, resveratrol, and the compounds PYC and enzogenol, are the phytochemical components of conifer extracts reported to have sedative, antidiabetic, anticancer and anesthetic effects. In addition, phytochemicals present in conifer extracts assist in the regulation of glucose and lipid metabolism, insulin secretion, stimulating β cells, the NF-kB signaling pathway, the inhibition of gluconeogenic enzymes, ROS protective action as well as targeting and modulating cytokines which affect neuron cells and reduce oxidative stress. In this way, conifers’ phytochemicals are used as an alternative to synthetic drugs and can be to a greater extent in the future, as they can be helpful in the formulation of new drugs. Without a doubt, conifers’ phytochemicals are the natural sources of future drugs; in the field of drug discovery, a large number studies into phytochemicals are still required. More efforts are needed to investigate and assess the clinical potential and molecular characterization of medicinal compounds with the help of databases and interdisciplinary group efforts.
Supplementary Materials
The following are available online, Table S1: Antiviral, antibacterial and antifungal activity of different conifers’ extracts.
Author Contributions
Conceptualization, A.S.S., P.B., N.C.-M. and K.K.; Writing—review, K.B., R.S. (Rohit Sharma), R.S. (Ruchi Sharma), D.S.D. and M.A.A.; Editing, M.A., E.N., K.M., B.S., N.K.U., M.N.; Funding acquisition, N.C.-M., K.M. and K.K. All authors have read and agreed to the published version of the manuscript.
Funding
This research was funded by University of Hradec Kralove (Faculty of Science VT 2019-2021).
Acknowledgments
We acknowledge the University of Hradec Kralove (Faculty of Science VT2019-2021) for financial support.
Conflicts of Interest
The authors declare no conflict of interest.
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Figures and Tables
Figure 2. Structures of phytochemical compounds present in different conifer spp.
Figure 2. Structures of phytochemical compounds present in different conifer spp.
Figure 2. Structures of phytochemical compounds present in different conifer spp.
Figure 3. Action mechanism of conifers’ phytochemical compounds in oxidative stress, apoptosis, and neurodegenerative diseases. The phytochemicals’ multi-target effects in the brain include mitochondrial protection, anti-aggregation, anti-oxidant, anti-apoptotic and anti-inflammatory activity.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
© 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
Abstract
Conifers have long been recognized for their therapeutic potential in different disorders. Alkaloids, terpenes and polyphenols are the most abundant naturally occurring phytochemicals in these plants. Here, we provide an overview of the phytochemistry and related commercial products obtained from conifers. The pharmacological actions of different phytochemicals present in conifers against bacterial and fungal infections, cancer, diabetes and cardiovascular diseases are also reviewed. Data obtained from experimental and clinical studies performed to date clearly underline that such compounds exert promising antioxidant effects, being able to inhibit cell damage, cancer growth, inflammation and the onset of neurodegenerative diseases. Therefore, an attempt has been made with the intent to highlight the importance of conifer-derived extracts for pharmacological purposes, with the support of relevant in vitro and in vivo experimental data. In short, this review comprehends the information published to date related to conifers’ phytochemicals and illustrates their potential role as drugs.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details
; Ana Sanches Silva 2
; Atanassova, Maria 3 ; Sharma, Rohit 4
; Nepovimova, Eugenie 5 ; Musilek, Kamil 5
; Sharma, Ruchi 6
; Alghuthaymi, Mousa A 7 ; Daljeet Singh Dhanjal 8
; Nicoletti, Marcello 9 ; Sharma, Bechan 10
; Upadhyay, Navneet Kumar 11
; Cruz-Martins, Natália 12
; Bhardwaj, Prerna 1 ; Kuča, Kamil 5
1 School of Biological and Environmental Sciences, Shoolini University of Biotechnology and Management Sciences, Solan 173229, India;
2 National Institute for Agricultural and Veterinary Research (INIAV), I.P., Vairão, 4485-655 Vila do Conde, Portugal;
3 Scientific Consulting, Chemical Engineering, University of Chemical Technology and Metallurgy, 1734 Sofia, Bulgaria;
4 Department of Rasashastra and Bhaishajya Kalpana, Faculty of Ayurveda, Institute of Medical Sciences, Banaras Hindu University, Varanasi 221005, India;
5 Department of Chemistry, Faculty of Science, University of Hradec Kralove, 50003 Hradec Kralove, Czech Republic;
6 School of Bioengineering & Food Technology, Shoolini University of Biotechnology and Management Sciences, Solan 173229, India;
7 Biology Department, Science and Humanities College, Shaqra University, Alquwayiyah 11971, Saudi Arabia;
8 School of Bioengineering and Biosciences, Lovely Professional University, Phagwara 144411, India;
9 Department of Environmental Biology, Sapienza University of Rome, Square Aldo Moro, 5, 00185 Rome, Italy;
10 Department of Biochemistry, University of Allahabad, Allahabad 211002, India;
11 School of Pharmaceutical Sciences, Shoolini University of Biotechnology and Management Sciences, Solan 173229, India;
12 Faculty of Medicine, University of Porto, 4200-319 Porto, Portugal; Institute for Research and Innovation in Health (i3S), University of Porto, 4200-135 Porto, Portugal; CESPU, Instituto de Investigação e Formação Avançada em Ciências e Tecnologias da Saúde, Rua Central de Gandra, 1317, 4585-116 Gandra PRD, Portugal




